.jpg "India May Scrap 60 percent Shelf Life Rule for Imported Drugs")
The Imported Drug Shelf Life Rule could soon see a major change in India. The Central government has proposed scrapping the existing 60 percent residual shelf life requirement for imported medicines and replacing it with a simpler 12-month rule.
The Centre is planning a major regulatory change that could make drug import license procedures easier for pharmaceutical companies involved in early-stage research.
Lupin secures a tentative approval from the USFDA further expanding India as the global leader in the pharmaceutical industry the drug actively blocks testosterone from stimulating cancer cell growth
.jpg "Government Demands 1 year Residual Shell Life for Imported Drugs")
A new rule comes into line for expanding the residual shell life of imported drugs in India,amid the wastage of medicines and the capital loss in operation and supply chain management
Alembic Pharma has gained entry into the USD 27 million US flu drug market after receiving USFDA approval for its generic flu drug, Oseltamivir Phosphate for Oral Suspension.
A packaging loophole allegedly helped counterfeit medicines enter global markets using genuine-looking pharmaceutical packaging.
Air Suvidha 2.0 is now mandatory for all international passengers arriving in India as the government steps up airport health screening amid the ongoing Ebola outbreak in parts of Africa.
Patients with rare cancer mutations in India now have access to a globally approved treatment option. Tanstrive, a targeted cancer therapy from Eli Lilly, has been launched in the country for patients with RET-altered tumors.
India’s Blood Standards Could Transform Patient Safety as India becomes the first country in the world to introduce exclusive standards for blood and blood components under the Indian Pharmacopoeia 2026.
As the miracle drug cure for cancer Keytruda nears expiry almost seven Indian manufacturers are set on a race to develop generic versions of the drug.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")